Blueprint Medicines Corp

CHARLES SCHWAB INVESTMENT MANAGEMENT INC BPMC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/12/2025

Shares

561,159

Value ($000)

71,929

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/12/2025	71,929	0.0%	561,159	6/30/2025
2025 Q1	9/15/2025	53,081	0.0%	599,721	3/31/2025
2024 Q4	2/6/2025	52,716	0.0%	604,397	12/31/2024
2024 Q3	11/12/2024	55,244	0.0%	597,232	9/30/2024
2024 Q2	8/12/2024	58,901	0.0%	546,496	6/30/2024
2024 Q1	5/9/2024	47,538	0.0%	501,135	3/31/2024
2023 Q4	2/6/2024	43,912	0.0%	476,063	12/31/2023
2023 Q3	11/8/2023	23,524	0.0%	468,417	9/30/2023
2023 Q2	8/10/2023	30,493	0.0%	482,483	6/30/2023
2023 Q1	5/12/2023	21,275	0.0%	472,890	3/31/2023
2022 Q4	2/13/2023	20,523	0.0%	468,459	12/31/2022
2022 Q3	11/14/2022	30,159	0.0%	457,709	9/30/2022
2022 Q2	8/15/2022	22,488	0.0%	445,218	6/30/2022
2022 Q1	5/13/2022	28,609	0.0%	447,849	3/31/2022
2021 Q4	2/11/2022	46,914	0.0%	437,995	12/31/2021
2021 Q3	11/16/2021	47,870	0.0%	465,609	9/30/2021
2021 Q2	8/16/2021	40,637	0.0%	461,993	6/30/2021
2021 Q1	5/17/2021	43,536	0.0%	447,755	3/31/2021
2020 Q4	2/16/2021	46,248	0.0%	412,374	12/31/2020
2020 Q3	11/13/2020	36,486	0.0%	393,592	9/30/2020
2020 Q2	8/20/2020	30,655	0.0%	393,002	6/30/2020
2020 Q1	5/15/2020	21,366	0.0%	365,355	3/31/2020
2019 Q4	2/7/2020	24,792	0.0%	309,471	12/31/2019